Hassan M - Search Results

1

Inhibitory effect of 5-fluorouracil on cytochrome P450 2C9 activity in cancer patients.

Gunes A, Coskun U, Boruban C, Gunel N, Babaoglu MO, Sencan O, Bozkurt A, Rane A, Hassan M, Zengil H, Yasar U. Gunes A, et al. Among authors: hassan m. Basic Clin Pharmacol Toxicol. 2006 Feb;98(2):197-200. doi: 10.1111/j.1742-7843.2006.pto_304.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16445595 Free article. Clinical Trial.

2

Pharmacogenetics of cyclophosphamide in patients with hematological malignancies.

Xie H, Griskevicius L, Ståhle L, Hassan Z, Yasar U, Rane A, Broberg U, Kimby E, Hassan M. Xie H, et al. Among authors: hassan m, hassan z. Eur J Pharm Sci. 2006 Jan;27(1):54-61. doi: 10.1016/j.ejps.2005.08.008. Epub 2005 Sep 23. Eur J Pharm Sci. 2006. PMID: 16183265 Clinical Trial.

3

Effect of cyclophosphamide on gene expression of cytochromes p450 and beta-actin in the HL-60 cell line.

Xie HJ, Lundgren S, Broberg U, Finnström N, Rane A, Hassan M. Xie HJ, et al. Among authors: hassan m. Eur J Pharmacol. 2002 Aug 9;449(3):197-205. doi: 10.1016/s0014-2999(02)01995-7. Eur J Pharmacol. 2002. PMID: 12167460

4

Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation.

Xie HJ, Yasar U, Lundgren S, Griskevicius L, Terelius Y, Hassan M, Rane A. Xie HJ, et al. Among authors: hassan m. Pharmacogenomics J. 2003;3(1):53-61. doi: 10.1038/sj.tpj.6500157. Pharmacogenomics J. 2003. PMID: 12629583

5

Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes.

Griskevicius L, Yasar U, Sandberg M, Hidestrand M, Eliasson E, Tybring G, Hassan M, Dahl ML. Griskevicius L, et al. Among authors: hassan m. Eur J Clin Pharmacol. 2003 Jun;59(2):103-9. doi: 10.1007/s00228-003-0590-6. Epub 2003 Apr 9. Eur J Clin Pharmacol. 2003. PMID: 12684728

6

Cyclophosphamide induces mRNA, protein and enzyme activity of cytochrome P450 in rat.

Xie H, Afsharian P, Terelius Y, Mirghani RA, Yasar U, Hagbjörk AL, Lundgren S, Hu Y, Rane A, Hassan M. Xie H, et al. Among authors: hassan m. Xenobiotica. 2005 Mar;35(3):239-51. doi: 10.1080/00498250500057369. Xenobiotica. 2005. PMID: 16019949

7

Alteration of pharmacokinetics of cyclophosphamide and suppression of the cytochrome p450 genes by ciprofloxacin.

Xie HJ, Broberg U, Griskevicius L, Lundgren S, Carlens S, Meurling L, Paul C, Rane A, Hassan M. Xie HJ, et al. Among authors: hassan m. Bone Marrow Transplant. 2003 Feb;31(3):197-203. doi: 10.1038/sj.bmt.1703815. Bone Marrow Transplant. 2003. PMID: 12621481

8

A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients.

Hassan M, Svensson US, Ljungman P, Björkstrand B, Olsson H, Bielenstein M, Abdel-Rehim M, Nilsson C, Johansson M, Karlsson MO. Hassan M, et al. Br J Clin Pharmacol. 1999 Nov;48(5):669-77. doi: 10.1046/j.1365-2125.1999.00090.x. Br J Clin Pharmacol. 1999. PMID: 10594468 Free PMC article. Clinical Trial.

9

The effect of repeated administration of cyclophosphamide on cytochrome P450 2B in rats.

Afsharian P, Terelius Y, Hassan Z, Nilsson C, Lundgren S, Hassan M. Afsharian P, et al. Among authors: hassan m, hassan z. Clin Cancer Res. 2007 Jul 15;13(14):4218-24. doi: 10.1158/1078-0432.CCR-07-0320. Clin Cancer Res. 2007. PMID: 17634551

10

Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation.

El-Serafi I, Afsharian P, Moshfegh A, Hassan M, Terelius Y. El-Serafi I, et al. Among authors: hassan m. PLoS One. 2015 Nov 6;10(11):e0141979. doi: 10.1371/journal.pone.0141979. eCollection 2015. PLoS One. 2015. PMID: 26544874 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,136 results

Search Page

Filters